Skip to main content
Aqua Bio Technology logo

Aqua Bio Technology — Investor Relations & Filings

Ticker · ABT ISIN · NO0010307135 LEI · 529900RG33DF0N88RJ88 Euronext Expand Manufacturing
Open in API
Filings indexed 1,254 across all filing types
Latest filing 2026-04-27 Report Publication Anno…
Country NO Norway
Listing Euronext Expand ABT

About Aqua Bio Technology

https://aquabiotechnology.com/

Aqua Bio Technology (ABT) is a biotechnology company that develops, manufactures, and commercializes natural and sustainable active ingredients for the international cosmetics and skincare industry. The company leverages science and technology to discover ingredients from natural sources, including plants, algae, and marine life. Its portfolio is centered on providing sustainable alternatives to petroleum-based substances. A key proprietary ingredient is Aquabeautine XL™, which is derived from proteins found in the hatching fluid of salmon, demonstrating a focus on upcycling biological byproducts into high-value cosmetic components. ABT's products cater to the increasing demand for effective and environmentally conscious skincare solutions.

Recent filings

Filing Released Lang Actions
Finansiell kalender
Report Publication Announcement Classification · 93% confidence The document is a financial calendar listing upcoming dates for the annual report (Årsrapport), half‐year report (Halvårsrapport), and the ordinary general meeting. It does not contain the reports themselves, but announces the timing of their publication. This fits the definition of a Report Publication Announcement (RPA).
2026-04-27 Norwegian
Aqua Bio Technology ASA: Godkjent prospekt - Attachment: 260421 Aqua Bio Technology ASA Prospectus.pdf
Share Issue/Capital Change Classification · 85% confidence The document is a full listing prospectus for 12,000,000 new shares issued in connection with a private placement and debt conversion, prepared under the EU Prospectus Regulation for admission to trading on Euronext Expand. It is not an annual or interim financial report, earnings release, or management announcement, but a detailed share issuance document. The most fitting category in our taxonomy is ‘Share Issue/Capital Change’ (SHA).
2026-04-21 English
Aqua Bio Technology ASA: Godkjent prospekt - Attachment: Aqua Bio Technology ASA- Godkjent prospekt.pdf
Report Publication Announcement Classification · 75% confidence The document is a press release (“Pressemelding”) announcing that the listing prospectus has been approved by Finanstilsynet and is attached/available on the company’s website. It does not contain the full report itself but rather notifies stakeholders of its publication. This fits the definition of a Report Publication Announcement (RPA).
2026-04-21 Norwegian
Aqua Bio Technology ASA: Godkjent prospekt
Report Publication Announcement Classification · 75% confidence The document is a short market announcement stating that the company’s approved prospectus is attached and available on its website following regulator approval. It does not contain the full prospectus itself but simply announces its publication. This fits the definition of a Report Publication Announcement (RPA).
2026-04-21 Norwegian
Aqua Bio Technology ASA: Oppdatering på refinansiering, prospekt og Jetcarrier - Attachment: Aqua Bio Technology ASA- Oppdatering på refinansiering, prospekt og Jetcarrier.pdf
Capital/Financing Update Classification · 90% confidence The document is a corporate press release by Aqua Bio Technology ASA providing an update on refinancing transactions: a directed share issue, rights issue, debt conversions, extension of debt for Jetcarrier sellers, and prospectus timing. It focuses on fundraising and capital structure changes rather than reporting periodic financials or listing full reports. This fits the Capital/Financing Update category.
2026-04-10 Norwegian
Aqua Bio Technology ASA: Oppdatering på refinansiering, prospekt og Jetcarrier
Capital/Financing Update Classification · 90% confidence The document is an update on recent refinancing activities, including directed share issuances, debt conversions, extension of debt maturities, and a forthcoming listing prospectus. It details capital structure changes and fundraising transactions rather than providing full financial statements or simply announcing the publication of a report. This aligns with the Capital/Financing Update category.
2026-04-10 Norwegian

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.